News
-
-
-
PRESS RELEASE
Telomir Pharmaceuticals Demonstrates Telomir-1 Reverses Key Drivers of Cellular Decline in Human Cell Lines Supporting Therapeutic Potential in Autism and Spasmodic Dysphonia
Telomir Pharmaceuticals announces new preclinical data on Telomir-1 drug candidate showing reversal of cellular decline in multiple human cell lines, leading to new research initiatives in autism and spasmodic dysphonia -
-
-
PRESS RELEASE
Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells
Telomir-1 by Telomir Pharmaceuticals demonstrates tumor growth inhibition by 50% in prostate cancer model, suppresses cancer progression, and neutralizes chemotherapy toxicity, providing breakthrough findings -
-
-
PRESS RELEASE
Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines
Telomir Pharmaceuticals announces new study findings showing Telomir-1 reverses oxidative stress, prevents cell death, and protects mitochondria, offering broad-spectrum therapeutic potential -
